Substrate-specific impairment of mitochondrial respiration in permeabilized fibers from patients with coronary heart disease versus valvular disease

Molecular and Cellular Biochemistry

Volumn 379, Issue 1-2, 2013, Pages 229-234

  Duicu, Oana ^a   Juşcǎ, Cǎlin ^a   Falniţǎ, Lucian ^a   Miricǎ, Silvia ^a   Maximov, Daniela ^a   Firǎ Mladinescu, Ovidiu ^a   Muntean, Danina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Coronary heart disease; High resolution respirometry; Human atrial permeabilized fibers; Valvular disease

Indexed keywords

CARDIOLIPIN; CYTOCHROME C; GLUTAMIC ACID; MALIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SAPONIN; SUPEROXIDE;

ADULT; ARTICLE; CARDIAC PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; DYSLIPIDEMIA; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART ATRIUM APPENDAGE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OBESITY; OXIDATIVE PHOSPHORYLATION; RESPIRATION CONTROL; RESPIRATORY FUNCTION; RESPIROMETRY; RISK FACTOR; VALVULAR HEART DISEASE;

AGED; CARBOHYDRATE METABOLISM; CELL RESPIRATION; CORONARY ARTERY DISEASE; ELECTRON TRANSPORT; FEMALE; GLUTAMIC ACID; HEART VALVE DISEASES; HUMANS; MALATES; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PERMEABILITY; SAPONINS;

ANIMALIA;

EID: 84878471128     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1644-4     Document Type: Article

References (33)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ et al (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046
2. Mahotra E (2012) The changing burden of valvular heart disease. BCS editorial. http://www.bcs.com/pages/news-full.asp?NewsID=1979205907. Accessed 07 Jun 2012
3. Di Lisa F, Canton M, Menabo R, Dodoni G, Bernardi P (2003) Mitochondria and reperfusion injury. The role of permeability transition. Basic Res Cardiol 98(4):235-241
4. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL (2001) Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging and heart failure. J Mol Cell Cardiol 33:1065-1089. doi: 10.1006/jmcc.2001.1378
5. Lemieux H, Hoppel CL (2009) Mitochondria in the human heart. J Bioenerg Biomembr 41:99-106. doi: 10.1007/s10863-009-9211-0
6. Lemieux H, Semsroth S, Antretter H, Höfer D, Gnaiger E (2011) Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol 43:1729-1738. doi: 10.1016/j.biocel.2011.08.008
7. Casademont J, Miró O (2002) Electron transport chain defects in heart failure. Heart Fail Rev 7:131-139
8. Stanley WC, Recchia FA, Lopaschuk GD (2004) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093-1129. doi: 10.1152/physrev.00006.2004
9. Marín-García J, Goldenthal MJ (2008) Mitochondrial centrality in heart failure. Heart Fail Rev 13:137-150. doi: 10.1007/s10741-007-9079-1
10. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, Heras M et al (2000) Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 45:860-865. doi: 10.1016/S0008-6363(99)00388-0
11. Kuznetsov AV, Veksler V, Gellerich FN, Saks V, Margreiter R, Kunz WS (2008) Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 3(6):965-976. doi: 10.1038/nprot.2008.61
12. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA (1987) Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892:191-196. doi: 10.1016/0005-2728(87)90174-5
13. Kuznetsov AV, Clark JF, Winkler K, Kunz WS (1996) Increase of flux control of cytochrome c oxidase in copper-deficient mottled brindled mice. J Biol Chem 271:283-288. doi: 10.1074/jbc.271.1.283
14. Skladal D, Sperl W, Schranzhofer R, Krismer M, Gnaiger E, Margreiter R, Gellerich FN (1994) Preservation of mitochondrial functions in human skeletal muscle during storage in high energy preservation solution (HEPS). In: Gnaiger E, Gellerich FN, Wyss M (eds) What is controlling life?, vol 3., Modern Trends in BiothermokineticsInnsbruck University Press, Innsbruck, pp 268-271
15. Duicu O, Gheorgheosu D, Mirica N, Trancota S, Dehelean C, Fira-Mladinescu O, Muntean D (2012) High-resolution repsirometry with multiple substrates titration in permeabilized myocardial fibers. Rev Med Chir Soc Med Nat Iasi 116(1):207-213
16. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Flemming D (2007) Patients with Type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790-796. doi: 10.1007/s00125-007-0594-3
17. Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M et al (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genetics 40:170-180. doi: 10.1038/ng.2007.62
18. Gnaiger Erich (2009) Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology. The International Journal of Biochemistry & Cell Biology 41:1837-1845. doi: 10.1016/j.biocel.2009.03.013
19. Gnaiger E, Steinlechner-Maran R, Méndez G, Eberl T, Margreiter R (1995) Control of mitochondrial and cellular respiration by oxygen. J Bioenerg Biomembr 27:583-596. doi: 10.1007/bf02111656
20. Gnaiger E (2008) Polarographic oxygen sensors, the oxygraph and high-resolution respirometry to assess mitochondrial function. In: Dykens JA, Will Y (eds) Mitochondrial dysfunction in drug-induced toxicity. Wiley, New Jersey, pp 327-352
21. Montaigne D, Marechal X, Preau S, Baccouch R, Modine T et al (2011) Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium. Mitochondrion 11:22-26. doi: 10.1016/j.mito.2010.06.001
22. Paradies G, Petrosillo G, Pistolese M, Di VN, Federici A, Ruggiero FM (2004) Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res 94:53-59. doi: 10.1161/01.RES.0000109416.56608.64
23. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero FM (1999) Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med 27:42-50. doi: 10.1016/S0891-5849(99)00032-5
24. Petrosillo G, Ruggiero FM, Di Venosa N, Paradies G (2003) Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J 17:714-716. doi: 10.1096/fj.02-0729fje
25. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G (1991) Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122:795-801. doi: 10.1016/0002-8703(91)90527-O
26. Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK (1991) Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 338(8773):973-976. doi: 10.1016/0140-6736(91)91838-L
27. Neubauer S (2007) The failing heart - an engine out of fuel. N Engl J Med 356:1140-1151. doi: 10.1056/NEJMra063052
28. Saks VA, Belikova YO, Kuznetsov AV, Khuchua ZA, Branishte TH, Semenovsky ML et al (1991) Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy. Am J Physiol 261:30-38
29. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN (2000) Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 32:2361-2367. doi: 10.1006/jmcc.2000.1266
30. Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, Geny B et al (2009) Control by circulating factors of mitochondrial function and transcription cascade in heart failure. A role for endothelin-1 and angiotensin II. Circulation 2:342-350. doi: 10.1161/CIRCHEARTFAILURE.108.812099
31. Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101-127. doi: 10.1124/pr.54.1.101
32. Neustadt J, Pieczenik SR (2008) Medication-induced mitochondrial damage and disease. Mol Nutr Food Res 52:780-788. doi: 10.1002/mnfr.200700075
33. Walters AM, Porter GA Jr, Brookes PS (2012) Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res 111(9):1222-1236. doi: 12.1161/CIRCRESAHA.112.265660